Colgate-Palmolive Company

🇺🇸New York Stock Exchange
Back to all articles
Colgate-Palmolive Company stock analysis CL overview
Bullish +70

Colgate-Palmolive’s Q1 Earnings Call: Our Top 5 Analyst Questions

📈 Colgate-Palmolive reported Q1 2026 revenue of $5.32 billion, surpassing Wall Street estimates of $5.23 billion with 8.4% year-on-year growth.

💰 Adjusted EPS reached $0.97 compared to analyst expectations of $0.94, representing a 2.7% positive surprise.

🛡️ Operating margins declined to 18.1% from 21.9% in the prior year quarter despite strong top-line performance.

🌏 Emerging markets, particularly Asia Pacific and India, were credited with driving broad-based growth through successful interventions and innovation.

💸 Raw material costs increased by $300 million, primarily due to rising oil-based input prices impacting the company's cost structure.

📉 Organic revenue growth was measured at 2.9% year on year, which beat analyst expectations while sales volumes rose 1.1%.

🗣️ CEO Noel Wallace emphasized strategic resets for North America to address volume challenges and improve market share.

🇨🇳 Performance in China and India was highlighted as critical factors driving growth in the Asia Pacific region through digital execution.

📉 Analysts expressed concern about gross margin headwinds, with management expecting lower margins throughout the fiscal year despite pricing strategies.

🤖 CFO Stanley Sutula noted that productivity enhancements and pricing actions are key mitigation strategies against inflationary pressures.

🚀 Management highlighted late-quarter innovation in the U.S. Oral Care segment as a catalyst for expected sequential gains.

⏭️ Investors will be watching emerging market momentum persistence, North America strategy effectiveness, and cost inflation offsetting capabilities in future quarters.

Bullish Signals
  • Colgate-Palmolive's Q1 results exceeded Wall Street expectations, with revenue of $5.32 billion beating analyst estimates of $5.23 billion by 1.8%.
  • Adjusted EPS beat forecasts at $0.97 versus the estimated $0.94, representing a positive performance for investors.
  • CEO Noel Wallace highlighted that emerging markets have accelerated, driving broad-based growth across categories and geographies.
  • Successful interventions in the Hawley & Hazel business and continued investments in advertising are serving as key drivers of this momentum.
  • Sales volumes rose 1.1% year-on-year, indicating underlying consumer demand strength after a negative quarter the previous year.
  • Management confirmed that organic revenue grew by 2.9%, reinforcing positive sales performance despite margin headwinds.
  • Strong performance in key Asian markets like China and India is being supported by innovation, digital execution, and strategic resets.
Risk Factors
  • Operating margins contracted significantly, dropping from 21.9% last year to 18.1%, indicating persistent pressure on profitability.
  • The CFO highlighted a $300 million increase in costs driven by inflation in oil-based raw material inputs, creating margin headwinds that pricing and productivity must offset.
  • Management explicitly lowered expectations for gross margins for the full year despite efforts to mitigate cost pressures.
  • Volume growth in North America remains a key concern as it trails emerging markets, requiring a strategic reset to improve share gains.
  • The company faces sustained competition in the U.S. Oral Care segment and must work to regain lost market share.
  • Analysts are closely watching the sustainability of volume growth in emerging markets following accelerated but potentially cyclical performance.
Full Analysis
Colgate-Palmolive reported Q1 2026 results that surpassed Wall Street expectations for revenue and non-GAAP profit, driven by accelerated sales volumes and robust performance in emerging markets, particularly within the Asia Pacific region. Revenue reached $5.32 billion, an 8.4% year-on-year increase that beat analyst estimates of $5.23 billion, while adjusted EPS came in at $0.97 compared to the estimated $0.94. Management highlighted successful interventions in the Hawley & Hazel business and continued investment in advertising and innovation as key growth drivers across categories and geographies. Despite the positive momentum, operating margins declined to 18.1% from 21.9% in the prior year quarter due to a $300 million increase in costs, primarily from oil-based inputs. To mitigate these headwinds, CFO Stanley Sutula noted plans for productivity improvements and pricing adjustments. Growth was further supported by organic revenue rising 2.9% year-over-year and sales volumes increasing by 1.1%. CEO Noel Wallace emphasized ongoing brand investment to sustain volume growth in emerging markets while executing a strategic reset in North America to regain market share. Analyst Q&A sessions revealed key concerns and management responses regarding sustainability, inflation, and regional performance. Investors from major firms like Morgan Stanley, Citi, Goldman Sachs, Bank of America, and JPMorgan questioned the path forward in North America, raw material cost pressures, gross margin flexibility, and the specific role of India and China. Management addressed these points by citing innovation, digital execution, and supply chain simplification as critical factors for long-term execution and margin recovery. The stock closed at $87.25, up from $85.36 prior to earnings, with the company's market capitalization standing at approximately $69.9 billion.